BIA reacts to eXmoor pharma investment
Reacting to new that eXmoor pharma has secured £12m of investment, Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA) said: “This is great news for UK medicine manufacturing. The investment into eXmoor’s cutting edge process development and clinical manufacturing in the south west of England will create long term highly skilled jobs. Anchoring next generation scale up and manufacturing in the UK will help ensure NHS patients will be amongst the first to benefit from new gene therapies as they develop in the coming years.”
To read more about the investment please follow this link.